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Abstract Escherichia coli maltose-binding protein (MBP) is
frequently used as an a⁄nity tag to facilitate the puri¢cation
of recombinant proteins. An important additional attribute of
MBP is its remarkable ability to enhance the solubility of its
fusion partners. MBPs are present in a wide variety of micro-
organisms including both mesophilic and thermophilic bacteria
and archaea. In the present study, we compared the ability of
MBPs from six diverse microorganisms (E. coli, Pyrococcus
furiosus, Thermococcus litoralis, Vibrio cholerae, Thermotoga
maritima, and Yersinia pestis) to promote the solubility of eight
di¡erent aggregation-prone proteins in E. coli. In contrast to
glutathione S-transferase (GST), all of these MBPs proved to
be e¡ective solubility enhancers and some of them were even
more potent solubilizing agents than E. coli MBP.
* 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
The expression of recombinant proteins in Escherichia coli
is frequently hampered by poor solubility. Sometimes insolu-
ble proteins that are deposited in the form of inclusion bodies
can be denatured and refolded, but this is an uncertain and
time-consuming undertaking. One way to circumvent the
problem of inclusion body formation is to exploit the innate
ability that certain proteins have to enhance the solubility of
their fusion partners. Originally it was presumed that virtually
any highly soluble protein could function as a general solubi-
lizing agent, but this has not turned out to be the case. In a
systematic comparison, E. coli maltose-binding protein (MBP)
proved to be a much more e¡ective solubility enhancer than
glutathione S-transferase or thioredoxin despite the fact that
all three of these proteins are highly soluble [1]. It appears,
therefore, that the ability of one fusion partner to promote the
solubility of another is a relatively rare trait.
We reasoned that one way to gain some insight into the
properties of Eco MBP that make it such an unusually e¡ec-
tive solubilizing agent would be to compare the ability of
orthologous proteins to promote solubility; perhaps some
patterns would emerge that would reveal clues about the
mechanism of the solubilizing e¡ect. Moreover, because there
is no a priori reason to believe that nature optimized Eco
MBP for this task, we wondered if MBPs from other organ-
isms might be even better solubilizing agents. At the same
time, we were also curious to know if there is any correlation
between the thermostability of a protein and its ability to
function as an e¡ective solubilizing agent. Accordingly, we
selected ¢ve orthologs exhibiting varying degrees of amino
acid sequence identity with Eco MBP (Yersinia pestis (Ype),
85%; Vibrio cholerae (Vch), 68%; Thermotoga maritima
(Tma), 35%; Thermococcus litoralis (Tli), 30%; and Pyrococ-
cus furiosus (Pfu), 27%) and compared their ability to promote
the solubility of eight di¡erent aggregation-prone proteins in
E. coli. The Tma, Tli, and Pfu MBPs were from hyperther-
mophiles, whereas the Eco, Ype, and Vch MBPs were of me-
sophilic origin. An alignment of the six MBP sequences is
included in the web supplement (doi: 10.1016/S0014-5793
(03)00070-X).
2. Materials and methods
2.1. Native expression vectors
Native E. coli (Eco) MBP was expressed from pDW533 [2]. The
open reading frames (ORFs) encoding the mature MBPs (without
their N-terminal signal peptides) from Y. pestis (Ype), T. maritima
(Tma), T. litoralis (Tli), P. furiosus (Pfu) and V. cholerae (Vch) were
ampli¢ed by polymerase chain reaction (PCR) from the corresponding
genomic DNAs. The PCR products were then digested with the ap-
propriate restriction enzymes and ligated into either pET11c or
pET11d (Novagen) to yield the native expression vectors. The Ype
MBP gene was ampli¢ed with primers PE-819 (5P-CCT CCC ATA
TGA AAA TTG AAG AAG GTA AAC TGG TTA TC-3P) and PE-
820 (5P-CAG CCT GGA TCC TTA GGC CTT CGT GAT ACG
GGT TGC CGC ATC-3P), cut with NdeI and BamHI, and inserted
into pET11c to yield pJF1105. The Tma MBP gene was ampli¢ed with
PE-668 (5P-CCT CCC ATA TGA AAA TTG AAC AAA CAA AGC
TCA CCA TCT GGT CTT CCG AAA AGC AGG-3P) and PE-669
(5P-CAG CCT AGA TCT TAG GCC TTT TCT ATC TGT GCC
TTG ATT TTG TCC AC-3P), cut with NdeI and BglII, and inserted
into pET11c to yield pKM980. The Tli MBP gene was ampli¢ed with
PE-666 (5P-CCT CCC ATA TGA AAA TTG AAG AAG GAA AGA
TAG TAT TTG CTG TAG GAG G-3P) and PE-667 (5P-CAG CCT
AGA TCT TAG GCC TTG CTG TAT TGT TTA ACT AAT TCC
TCT G-3P), cut with NdeI and BglII, and inserted into pET11c to
yield pKM979. The Pfu MBP gene was ampli¢ed with PE-472 (5P-
CCT CCC ATA TGA AAA TCG AAG AAG GAA AAG TTG TTA
TTT GGC ATG CAA TG-3P) and PE-473 (5P-CAG CCT GGA TCC
ATT ATC CTT GCA TGT TGT TAA GGA TTT CTT G-3P), cut
with NdeI and BamHI, and inserted into pET11c to yield pKM820.
The Vch MBP gene was ampli¢ed with PE-874 (5P-CCT GCT CAT
GAA AAT TGA AGA AGG ACA ACT CAC TAT TTG G-3P) and
PE-875 (5P-CAG CCT GGA TCC TTA CCC GGG TTT CGT CAT
CTG CTT TTC AGC ATC-3P), cut with BspHI and BamHI, and
inserted into pET11d to yield pKM1136.
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2.2. Gateway destination vectors
The Gateway1 recombinational cloning system (Invitrogen) was
used to facilitate the construction of fusion protein expression vectors.
The Eco MBP destination vector, pKM596, was described previously
[3]. The Ype MBP destination vector, pJF1106, was constructed by
inserting the RfC Gateway cloning cassette into StuI-digested
pJF1105. The Tma MBP destination vector was constructed by insert-
ing the RfC cassette into StuI-digested pKM980. The Tli MBP desti-
nation vector was constructed by inserting the RfC cassette into StuI-
digested pKM979. The Pfu MBP destination vector was constructed
by inserting the RfA cassette between the unique SacI and BamHI
sites in a precursor of pKM820, after the sticky ends were blunted
with T4 DNA polymerase and dNTPs. The Vch MBP destination
vector was constructed by inserting the RfA cassette into SmaI-di-
gested pKM1136.
2.3. Gateway entry clones
The genes encoding p16, GFP, CATv9, and E6 were described
previously [1]. The cloned bovine rhodanese gene was obtained
from Dr. Paul M. Horowitz (University of Texas Health Science
Center at San Antonio, TX, USA). The luciferase gene originated
from the plasmid pZA31luc [4]. The G3PDH and DHFR ORFs
were obtained from the Invitrogen line of GeneStorm1 clones (cata-
log numbers M-M32599M and H-J00140M, respectively). To con-
struct the Gateway entry clones, each passenger protein ORF was
ampli¢ed by PCR, using a pair of gene-speci¢c primers with 5P ex-
tensions that added an in-frame TEV protease recognition site and a
hexahistidine tag to their N- and C-termini, respectively. Next, these
PCR amplicons were used as the templates for another PCR with
primers PE-277 and PE-278 [5], which are designed to anneal to the
sequences encoding the TEV protease recognition site and the His-tag,
respectively, and add attB1 and attB2 recombination sites to the ends
of the amplicon. The ¢nal PCR amplicons were inserted by recombi-
national cloning into the entry vector pDONR201 to create the entry
clones pKM992 (E6), pKM617 (GFP), pKM1038 (CATv9), pKM991
(E6), pJF849 (rhodanese), pJF853 (luciferase), pJF929 (G3PDH), and
pJF930 (DHFR). The nucleotide sequences of all eight ORFs were
veri¢ed experimentally.
2.4. Fusion protein expression vectors
48 MBP fusion protein expression vectors were constructed by re-
combining each passenger protein ORF (p16, GFP, CATv9, E6,
rhodanese, luciferase, G3PDH, and DHFR) into each MBP destina-
tion vector (Eco, Ype, Tma, Tli, Vch, Pfu), using the standard LxR
protocol (Invitrogen). The GST fusion protein expression vectors were
constructed in a similar fashion, using the destination vector pGST-
DV3 (Invitrogen).
2.5. Protein expression, sodium dodecyl sulfate^polyacrylamide gel
electrophoresis (SDS^PAGE) analysis, and densitometry
Protein expression experiments were performed as described previ-
ously [1] except that the tRNA accessory plasmid pRIL (Stratagene)
was included in all cases. Preparation of samples, SDS^PAGE, and
quantitative densitometry of the stained gels were all carried out es-
sentially as described [1]. Between three and ¢ve experiments were
performed to obtain the average solubility (and standard error) for
each fusion protein.
3. Results
3.1. Overproduction of unfused MBPs in E. coli
MBPs and other periplasmic solute-binding proteins are
present in a wide variety of microorganisms [6]. However,
thus far only E. coli MBP has been exploited to facilitate
the puri¢cation and enhance the solubility of recombinant
proteins [1,3,7^9]. The objective of this study was to determine
whether MBPs from other microorganisms can also function
as solubility enhancers in the context of a fusion protein. To
this end, ¢ve MBPs from diverse microbial sources were se-
lected for comparative analysis.
The mature domain of every MBP is preceded by a hydro-
phobic N-terminal leader sequence that either serves as a se-
cretion signal or a membrane anchor. In some cases (Vch,
Tma, Tli and Pfu), it was uncertain exactly where the leader
peptide ended and the mature domain began. For this reason,
and also to improve the odds of achieving e⁄cient translation
initiation in E. coli, the N-termini of these proteins were
modi¢ed to resemble that of the mature Eco MBP. Addition-
ally, to allow for the insertion of a Gateway1 cloning cassette
in the proper reading frame, one or two non-native residues
were added to the C-termini of some MBPs to create unique
restriction sites. The non-native residues are colored red in the
sequence alignment (see web supplement).
To begin with, each MBP was overproduced in E. coli to
assess its yield and solubility in the unfused state (Fig. 1). The
yields of the Ype, Vch, Tma, Tli and Pfu MBPs were very
similar to that of Eco MBP, easily comprising the majority
of the intracellular protein. Moreover, although a statistical
model [10] predicted that four of the six MBPs were likely to
be insoluble in E. coli, we found that all of them were highly
soluble at 37‡C. Tli MBP does not bind to amylose resin [11],
but all of the other MBPs were quantitatively retained on an
amylose column, indicating that they were properly folded
(data not shown).
3.2. Insolubility of GST fusion proteins in E. coli
Having established that all six MBPs are highly soluble in
an unfused state, next we compared their ability to promote
the solubility of eight di¡erent aggregation-prone passen-
ger proteins: human p16INK4, Aquorea victoria green £uores-
cent protein (GFP), chloramphenicol acetyltransferase-v9
(CATv9), human papillomavirus E6 oncoprotein, bovine
rhodanese, Photinus pyralis luciferase, murine glyceralde-
hyde-3-phosphate dehydrogenase (G3PDH), and human dihy-
drofolate reductase (DHFR). These proteins represent a wide
range of origins, sizes, and functions. Rhodanese, luciferase,
G3PDH and DHFR are commonly used as model substrates
for the molecular chaperone GroEL. The latter proteins are
also more di⁄cult to solubilize than most of the other pas-
sengers used in this study, and so they a¡ord an opportunity
for a more rigorous assessment of solubility enhancement.
As demonstrated previously, GST has virtually no ability to
enhance the solubility of its fusion partners [1]. Consequently,
the solubility of a GST fusion protein is a good indicator of
the solubility of its passenger protein in the unfused state. At
the same time, uniformly high expression levels are easier to
Fig. 1. Overproduction of unfused MBPs in E. coli. Samples of the
total (T) and soluble (S) intracellular protein fractions are shown
after SDS^PAGE. Abbreviations: Pfu, P. furiosus ; Tli, T. litoralis ;
Vch, V. cholerae ; Tma, T. maritima ; Eco, E. coli ; Ype, Y. pestis.
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obtain with GST fusions than would be the case with unfused
passengers. As shown in Fig. 2, all of the passenger proteins
used in this study are poorly soluble as GST fusions.
3.3. Solubility of MBP fusion proteins in E. coli
Next, 48 di¡erent MBP fusion protein expression vectors,
comprising all possible combinations of the six MBPs and the
eight passenger proteins, were constructed by Gateway1 re-
combinational cloning. The length and amino acid sequences
of the interdomain linkers were nearly identical in all of the
fusion proteins. The MBP fusion proteins were expressed in
E. coli and their solubility was estimated by SDS^PAGE and
densitometry. All of the fusion proteins were expressed at a
uniformly high level (data not shown). The quantitative re-
sults are summarized in Fig. 3.
All of the MBPs were more e¡ective solubilizing agents
than GST, but some were consistently better than others.
The best solubilizing agent was Pfu MBP, the most distant
relative of Eco MBP, whereas the closest relative of Eco MBP,
Ype MBP, was the least e¡ective overall. For the most part,
those passenger proteins that were solubilized most readily by
Ype MBP (GFP, p16 and E6) tended also to be solubilized
most e⁄ciently by the other MBPs, suggesting that the under-
lying mechanism of the solubilizing e¡ect is likely to be similar
for all six MBPs. The two passenger proteins that were con-
sistently most di⁄cult to solubilize, CATv9 and luciferase,
exhibited a dramatic increase in solubility when they were
fused to Pfu MBP. When the average solubility of each set
of MBP fusion proteins (Ype, Eco, Vch, Tma, Tli, Pfu) is
compared, the trend becomes even clearer (Fig. 4). From these
data, it can be seen that on average Pfu MBP is about 50%
more e¡ective than Eco MBP and almost twice as e¡ective as
Ype MBP at promoting the solubility of the eight passenger
proteins employed in this study. The average solubility of the
corresponding GST fusion proteins is negligible by compar-
ison.
4. Discussion
Although not every highly soluble protein can function as a
solubility enhancer, our results indicate that this is a common
property of MBPs from diverse microbial sources. In contrast
to GST, all six of the MBPs we tested were able to enhance
the solubility of aggregation-prone proteins to varying de-
grees. Unexpectedly, the closest relative of Eco MBP, Ype
MBP, proved to be the least e¡ective solubilizing agent. There
are 53 amino acid substitutions in Ype MBP relative to Eco
MBP, most of which are conservative in nature. Important
clues about the mechanism of the solubilizing e¡ect might
be uncovered by attempting to determine which amino acid
substitution(s) make the latter MBP a more e¡ective solubi-
lizing agent than the former.
Fig. 2. Insolubility of GST fusion proteins in E. coli. Samples of
the total (T) and soluble (S) intracellular proteins are shown after
SDS^PAGE. Abbreviations: G3PDH, glyceraldehyde-3-phosphate
dehydrogenase; DHFR, dihydrofolate reductase; p16, p16INK4 ;
GFP, green £uorescent protein; CATv9, a mutant of chlorampheni-
col acetyltransferase lacking the nine C-terminal residues; E6, hu-
man papillomavirus oncoprotein E6; RHOD, rhodanese; LUC, lu-
ciferase.
Fig. 3. Solubility of MBP fusion proteins in E. coli. Each fusion protein was expressed, analyzed by SDS^PAGE, and its solubility estimated
by laser densitometry. Error bars indicate the standard error for the solubility of each fusion protein. Abbreviations are given in the legends to
Figs. 1 and 2.
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It is conceivable that, among highly soluble proteins, the
larger ones tend to be the most e¡ective solubilizing agents.
This might explain why MBP consistently outperformed both
GST and thioredoxin in side-by-side comparisons [1].
Although a direct test of this hypothesis would be di⁄cult,
because any collection of highly soluble proteins of varying
sizes would be heterogeneous with respect to other properties
as well, the question can also be approached from a di¡erent
angle. If, in addition to the quality of being highly soluble in
E. coli, the ability of a protein to function as a solubility
enhancer depended primarily on its size, then soluble proteins
of similar size should be equally e¡ective solubilizing agents.
Yet, our results appear to contradict this prediction. All of the
MBPs tested in this study are highly soluble in E. coli and
approximately the same size, but they vary widely in their
e⁄cacy as solubilizing agents. Thus, if the size of the soluble
fusion partner makes any di¡erence, it seems unlikely to be
the principal factor.
The two best solubilizing agents identi¢ed in this study, Pfu
MBP and Tli MBP, are extremely thermostable proteins
[12,13], as is Tma MBP [14]. However, the latter protein
was a less e¡ective solubilizing agent than Vch MBP or Eco
MBP (Fig. 4), both of which are of mesophilic origin. The
thermostability of Vch MBP has not been formally investi-
gated, but Eco MBP is far less stable than Tma MBP
[15,16]. Therefore, it appears that thermophilic proteins are
not necessarily more e¡ective solubilizing agents than their
mesophilic counterparts.
What properties do all of these MBPs have in common that
might explain their ability to promote the solubility of their
fusion partners? For one thing, they are all very acidic pro-
teins with theoretical isoelectric points ranging between 4.41
(Pfu MBP) and 5.39 (Ype MBP). E. coli NusA, another e¡ec-
tive solubility enhancer [17], is also a very acidic protein
(pIV4.35). In contrast, the isoelectric points of GST
(pIV6.52) and chloramphenicol acetyltransferase (pIV6.36),
two highly soluble proteins that do not function as solubility
enhancers [1,18], are much closer to neutral. The correlation
between low isoelectric point and potency as a solubilizing
agent is intriguing and may be signi¢cant, but it is not stead-
fast; the predicted isoelectric point of thioredoxin (V5.21) is
the same as that of Tli MBP, but thioredoxin is a far less
e¡ective solubilizing agent than even Eco MBP [1]. Further
research will be required to ascertain whether or not acidic
proteins tend to be the most e¡ective solubilizing agents.
MBPs belong to a family of periplasmic solute-binding pro-
teins that interact with sugars and amino acids [6]. All of them
are involved in solute uptake or chemotaxis. The crystal struc-
tures of Eco, Tli and Pfu MBP revealed that although their
amino acid sequences are quite di¡erent, all three proteins
adopt a similar tertiary fold [12,13,19]. It therefore seems
likely that the other MBPs examined in this study also share
the same general architecture. It is possible that, for whatever
reason, this tertiary fold is particularly well-suited for solubil-
ity enhancement. If so, then even more distant relatives of
MBP within the superfamily of periplasmic solute-binding
proteins may also possess the ability to promote the solubility
of their fusion partners. Moreover, if the ability of a protein
to function as a solubility enhancer is correlated with its ter-
tiary structure, then the phylogenetic comparative approach
described here could also be used to identify orthologs of
other solubility enhancing proteins, like E. coli NusA [17],
with improved performance characteristics.
A potential practical advantage of the thermostable MBPs
(Tli, Tma, Pfu) may be their utility as ‘solubility handles’ for
refolding proteins. Not all passenger proteins that can be ren-
dered soluble by fusing them to MBP are able to fold sponta-
neously into their native, biologically active conformation.
Because the thermostable MBPs do not unfold in the presence
of high concentrations of urea or guanidine hydrochloride
[12^14], passenger proteins could be denatured and subse-
quently refolded while still fused to a folded MBP domain.
This approach might conceivably result in a greater yield of
properly folded protein than could be obtained by refolding
the same protein in the unfused state.
In conclusion, although relatively few proteins appear to be
generally e¡ective solubilizing agents [1], this seems to be a
common property of even distantly related maltodextrin-bind-
ing proteins. Some of these MBPs are clearly more e¡ective
solubilizing agents than E. coli MBP, but whether they will
also be more e¡ective at promoting the proper folding of their
fusion partners remains to be determined. Although many
polypeptides can be produced in a soluble form as MBP fu-
sion proteins, they are frequently unable to fold into their
native conformations but exist instead as soluble aggregates
[20,21]. Therefore, solubility is not a reliable indicator of
structural integrity and one must bear in mind that the
most e¡ective solubilizing agent may not necessarily be the
most e⁄cient ‘foldase’. This issue clearly needs to be ad-
dressed in the future, not only for the MBPs described here,
but also for other proteins that have been touted as solubiliz-
ing agents.
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